Charles A. Deignan, Clearside Biomedical, Inc.'s Chief Financial Officer, recently acquired 10,000 shares of the company. The buys took place at $1.36 per share, on March 15, 2019. Deignan now owns 76,356 shares of the company. Deignan operates out of Alpharetta, GA. Some additional info was provided as follows:
The above information was disclosed in a filing to the SEC. To see the filing, click here.
To receive a free e-mail notification whenever Clearside Biomedical, Inc. makes a similar move, sign up!
Other recent filings from the company include the following:
Clearside Biomedical, Inc. Just Received a Notice of Effectiveness - Jan. 17, 2020
Clearside Biomedical, Inc.'s CEO just picked up 66,250 shares - Jan. 10, 2020
Clearside Biomedical, Inc.'s Chief Financial Officer just picked up 25,000 shares - Jan. 10, 2020
Registration statement under Securities Act of 1933 - Jan. 10, 2020
Departure of Directors or Certain - Jan. 3, 2020